Giovanni Abbadessa M.D., Ph.D.
Head of Oncology Early Development
- Industry Roles: Sanofi: Head of Oncology Early Development since Sep 2019; Head of Isatuximab Non-myeloma Development since Apr 2017. ArQule (2009-2017): VP Oncology Clinical Development, Research, Medical Affairs. Ziopharm (2007-2009): Sr Dir Onco Clin Dev. Worked hands-on on IO antibodies, TKIs, chemos. Worked on solid tumors, hematological malignancies, and rare diseases in FIH, Ph1, RCT Ph2, Ph3 studies. Led teams of biologists, clinicians, in research, development, operations. Led partnerships, Joint Steering & Development Committees, relations with KOLs, advisory boards, investigator meetings. Supported Business Development, Investor Relations, Board management. Authored 40+ peer-reviewed articles, 70+ oral/poster presentations.
- Academic Experience: Leadership training at Harvard Business School (2011). PhD in Genetical Oncology at Univ of Siena, Italy / Temple Univ, Philadelphia, PA (2006-2010); Clinical Oncology fellowship at Humanitas, Milan / Univ of Genova, Italy (2001-2005); Medical School at Federico II University, Naples, Italy (1995-2001)
- Additional: Fluent in English, Italian, Spanish, basic in French. Founded and run a local nonprofit Saturday Italian school for children and parents, and a cultural Boston association. Sit in board of a local school and of an elected committee to represent Italians in Boston. Love skiing, sailing, travelling, tennis.